← Patent-cliff monitor small molecule FLYRCADO FLURPIRIDAZ F-18
Loss of exclusivity May 2042 latest FDA-listed patent expiry
Company GE HEALTHCARE INC
Drug detail Brand name FLYRCADO Active ingredient FLURPIRIDAZ F-18 Strength 5-55mCi/ML Dosage form SOLUTION Route INTRAVENOUS Modality Small molecule FDA approval September 2024 Marketing status RX
Listed patents Patent Expires Type 12527884 May 2042 product 9687571 November 2032 product 8936777 June 2031 use U-4011 9603951 May 2031 use U-4011 8226929 June 2028 use U-4011 7344702 May 2026 substance 9161997 February 2026 substance, product
Regulatory exclusivity Code Expires NCE September 2029
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.